332 related articles for article (PubMed ID: 27849645)
21. Cytogenetic risk stratification may predict allogeneic hematopoietic stem cell transplantation outcomes for chronic myelomonocytic leukemia.
Motohashi K; Fujisawa S; Doki N; Kobayashi T; Mori T; Usuki K; Tanaka M; Fujiwara S; Kako S; Aoyama Y; Onoda M; Yano S; Gotoh M; Kanamori H; Takahashi S; Okamoto S;
Leuk Lymphoma; 2018 Jun; 59(6):1332-1337. PubMed ID: 29032731
[TBL] [Abstract][Full Text] [Related]
22. Treatment advances for pediatric and adult onset neoplasms with monocytosis.
McCullough KB; Kuhn AK; Patnaik MM
Curr Hematol Malig Rep; 2021 Jun; 16(3):256-266. PubMed ID: 33728588
[TBL] [Abstract][Full Text] [Related]
23. Increasing recognition and emerging therapies argue for dedicated clinical trials in chronic myelomonocytic leukemia.
Renneville A; Patnaik MM; Chan O; Padron E; Solary E
Leukemia; 2021 Oct; 35(10):2739-2751. PubMed ID: 34175902
[TBL] [Abstract][Full Text] [Related]
24. Proposals for Clinical Trials in Chronic Myelomonocytic Leukemia.
Rezazadeh A; Deininger M; Atallah E
Curr Treat Options Oncol; 2023 Aug; 24(8):1036-1051. PubMed ID: 37300657
[TBL] [Abstract][Full Text] [Related]
25. Current Management and Recent Advances in the Treatment of Chronic Myelomonocytic Leukemia.
Hunter AM; Zhang L; Padron E
Curr Treat Options Oncol; 2018 Oct; 19(12):67. PubMed ID: 30367269
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of decitabine in the treatment of patients with chronic myelomonocytic leukemia (CMML).
Wijermans PW; Rüter B; Baer MR; Slack JL; Saba HI; Lübbert M
Leuk Res; 2008 Apr; 32(4):587-91. PubMed ID: 17881052
[TBL] [Abstract][Full Text] [Related]
27. Recent advances in diagnosis, molecular pathology and therapy of chronic myelomonocytic leukaemia.
Bacher U; Haferlach T; Schnittger S; Kreipe H; Kröger N
Br J Haematol; 2011 Apr; 153(2):149-67. PubMed ID: 21401573
[TBL] [Abstract][Full Text] [Related]
28. Chronic Myelomonocytic Leukemia: Insights into Biology, Prognostic Factors, and Treatment.
Coltro G; Patnaik MM
Curr Oncol Rep; 2019 Nov; 21(11):101. PubMed ID: 31728739
[TBL] [Abstract][Full Text] [Related]
29. Targeted deep sequencing improves outcome stratification in chronic myelomonocytic leukemia with low risk cytogenetic features.
Palomo L; Garcia O; Arnan M; Xicoy B; Fuster F; Cabezón M; Coll R; Ademà V; Grau J; Jiménez MJ; Pomares H; Marcé S; Mallo M; Millá F; Alonso E; Sureda A; Gallardo D; Feliu E; Ribera JM; Solé F; Zamora L
Oncotarget; 2016 Aug; 7(35):57021-57035. PubMed ID: 27486981
[TBL] [Abstract][Full Text] [Related]
30. Moving towards a uniform risk stratification system in CMML - How far are we?
Chan O; Padron E
Best Pract Res Clin Haematol; 2020 Jun; 33(2):101131. PubMed ID: 32460982
[TBL] [Abstract][Full Text] [Related]
31. Outcomes of patients with chronic myelomonocytic leukaemia treated with non-curative therapies: a retrospective cohort study.
Pleyer L; Leisch M; Kourakli A; Padron E; Maciejewski JP; Xicoy Cirici B; Kaivers J; Ungerstedt J; Heibl S; Patiou P; Hunter AM; Mora E; Geissler K; Dimou M; Jimenez Lorenzo MJ; Melchardt T; Egle A; Viniou AN; Patel BJ; Arnan M; Valent P; Roubakis C; Bernal Del Castillo T; Galanopoulos A; Calabuig Muñoz M; Bonadies N; Medina de Almeida A; Cermak J; Jerez A; Montoro MJ; Cortés A; Avendaño Pita A; Lopez Andrade B; Hellstroem-Lindberg E; Germing U; Sekeres MA; List AF; Symeonidis A; Sanz GF; Larcher-Senn J; Greil R
Lancet Haematol; 2021 Feb; 8(2):e135-e148. PubMed ID: 33513373
[TBL] [Abstract][Full Text] [Related]
32. The clinical management of chronic myelomonocytic leukemia.
Padron E; Komrokji R; List AF
Clin Adv Hematol Oncol; 2014 Mar; 12(3):172-8. PubMed ID: 24927265
[TBL] [Abstract][Full Text] [Related]
33. CMML: a biologically distinct myeloproliferative disease.
Cortes J
Curr Hematol Rep; 2003 May; 2(3):202-8. PubMed ID: 12901341
[TBL] [Abstract][Full Text] [Related]
34. How I treat chronic myelomonocytic leukemia.
Solary E; Itzykson R
Blood; 2017 Jul; 130(2):126-136. PubMed ID: 28572287
[TBL] [Abstract][Full Text] [Related]
35. A case of chronic myelomonocytic leukemia complicated with spondyloarthritis.
Matsumoto T; Saito T; Kohsaka H
Mod Rheumatol; 2018 Mar; 28(2):373-375. PubMed ID: 26392142
[TBL] [Abstract][Full Text] [Related]
36. Improving the accuracy of prognostication in chronic myelomonocytic leukemia.
Kaivers J; Schuler E; Hildebrandt B; Betz B; Rautenberg C; Haas R; Kobbe G; Gattermann N; Germing U
Expert Rev Anticancer Ther; 2020 Aug; 20(8):703-714. PubMed ID: 32700646
[TBL] [Abstract][Full Text] [Related]
37. Natural history of chronic myelomonocytic leukemia treated with hypomethylating agents.
Alfonso A; Montalban-Bravo G; Takahashi K; Jabbour EJ; Kadia T; Ravandi F; Cortes J; Estrov Z; Borthakur G; Pemmaraju N; Konopleva M; Bueso-Ramos C; Pierce S; Kantarjian H; Garcia-Manero G
Am J Hematol; 2017 Jul; 92(7):599-606. PubMed ID: 28370097
[TBL] [Abstract][Full Text] [Related]
38. Diagnosis and treatment of chronic myelomonocytic leukemia.
Kwon J
Blood Res; 2021 Apr; 56(S1):S5-S16. PubMed ID: 33935030
[TBL] [Abstract][Full Text] [Related]
39. Molecular predictors of response to decitabine in advanced chronic myelomonocytic leukemia: a phase 2 trial.
Braun T; Itzykson R; Renneville A; de Renzis B; Dreyfus F; Laribi K; Bouabdallah K; Vey N; Toma A; Recher C; Royer B; Joly B; Vekhoff A; Lafon I; Sanhes L; Meurice G; Oréar C; Preudhomme C; Gardin C; Ades L; Fontenay M; Fenaux P; Droin N; Solary E;
Blood; 2011 Oct; 118(14):3824-31. PubMed ID: 21828134
[TBL] [Abstract][Full Text] [Related]
40. Chronic myelomonocytic leukemia diagnosis and management.
Chan O; Renneville A; Padron E
Leukemia; 2021 Jun; 35(6):1552-1562. PubMed ID: 33714974
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]